Inflammation

OCS-01 eye drops demonstrated positive topline results for the treatment of inflammation and pain after cataract surgery, according to a press release from Oculis.

SEATTLE — Apellis Pharmaceuticals reported there is no indication that drug product or manufacturing issues contributed to recent reports of retinal vasculitis linked with Syfovre.

Among patients with ulcerative colitis, delayed Stelara responders had greater inflammatory burden at baseline compared with early responders, yet similar 1-year clinical remission outcomes, researchers reported.

The advancement of retinal therapies offers promise and hopefully no peril to those willing to push the boundaries of medical science into new indications.

Children and young adults who have longer sedentary time are more likely to have high C-reactive protein levels, an indicator of greater inflammation, according to study findings.

Dupilumab improved outcomes among patients with severe chronic rhinosinusitis with nasal polyps across a range of type 2 inflammatory signatures, according to data presented at EAACI Hybrid Congress 2023 in Hamburg, Germany.

WASHINGTON — At 52 weeks, adults with moderate/severe COPD and type 2 inflammation receiving dupilumab had a lower exacerbation rate and better lung function, according to an American Thoracic Society International Conference presentation.

A 0.5 mg dose of colchicine, a drug commonly used for conditions such as gout, was recently approved by the FDA to prevent cardiovascular events in patients with residual inflammatory risk.

Digestive Disease Week 2023 in Chicago may have ended in early May, but Healio coverage has continued all month long. Wondering what you missed and what is coming next? Healio recaps the biggest meeting news making waves in the specialty.

In this Healio | Cardiology Today video exclusive, Daniel Soffer, MD, FNLA, discussed some of the highlights so far from the National Lipid Association Scientific Sessions.